In This Section

Stephan Kadauke, MD, PhD
Stephan Kadauke
Associate Director, Cell and Gene Therapy Laboratory

Dr. Kadauke is the associate director of the Cell and Gene Therapy Laboratory at CHOP and the medical director of the Cell and Gene Therapy Informatics team. His research focuses on developing novel ways to manufacture cell therapies with the goal of accelerating and broadening patient access to these life-saving therapies.



Subscribe to be notified of changes or updates to this page.


Dr. Stephan Kadauke is a licensed physician with expertise in Clinical Pathology, Transfusion Medicine, Cell Therapy, and Clinical Informatics.

Dr. Kadauke is the associate director of the Cell and Gene Therapy Laboratory (CGTL) at the Children's Hospital of Philadelphia (CHOP). The CGTL is a cGMP facility embedded into the hospital that performs various procedures to process cell therapies and is the sole provider of cellular therapies at CHOP. Dr. Kadauke is involved in 50+ active investigator- and industry-sponsored cell therapy clinical trials exploring hemoglobin gene therapies, chimeric antigen receptor (CAR) T cells, hematopoietic stem cell (HSC) transplants, and virus-specific cytotoxic T cells. He also serves as the Associate Director of the Penn/CHOP Cell Therapy Fellowship program.

Dr. Kadauke also serves as attending physician on the Apheresis service, where he treats patients with sickle cell disease and various autoimmune and neurological diseases. He also supervises cell collections for patients who require stem cell transplantation or other cellular immunotherapies

In addition to his clinical work, Dr. Kadauke is the medical director of Cell and Gene Therapy Informatics (CGTI). CGTI is an agile team that builds systems to deliver reliable, high-quality, and timely data to Cell and Gene Therapy clinicians and researchers to help clinical decision making, improve and automate quality operations, and accelerate Cell and Gene Therapy clinical research. CGTI currently maintains 25+ separate systems, including REDCap-based clinical trial electronic data capture (EDC) systems, custom-built R packages and R/Shiny web applications, as well as machine learning-based predictive models.

Education and Training

BA, Columbia University (Biochemistry), 2005

PhD, University of Pennsylvania, 2012

MD, University of Pennsylvania, 2014

Fellowship, Harvard University (Transfusion Medicine), 2017

Residency, Harvard University (Clinical Pathology), 2018

Titles and Academic Titles

Assistant Professor of Clinical Pathology and Laboratory Medicine, University of Pennsylvania

Associate Director, Cell and Gene Therapy Laboratory, Children's Hospital of Philadelphia

Medical Director, Cell and Gene Therapy Informatics, Children's Hospital of Philadelphia

Associate Director, Penn/CHOP Cell Therapy Fellowship Program

Faculty Member, Department of Biomedical Health Informatics, Children's Hospital of Philadelphia

Faculty Member, Division of Pathology Informatics, Children's Hospital of Philadelphia

Attending Physician, Division of Transfusion Medicine, Children's Hospital of Philadelphia

Professional Memberships

AABB (formerly American Association of Blood Banks), 2017-

American Society of Apheresis, 2018-

International Society for Cellular Therapy, 2019-

College of American Pathologists, 2019-

Association for Pathology Informatics, 2019-

American Association for Clinical Chemistry, 2019-

R/Medicine, 2020-

American Society for Transplantation and Cellular Therapy (ASTCT), 2020-

American Medical Informatics Association (AMIA), 2021-

Professional Awards

Saul Winegrad Award for Outstanding Dissertation, 2013

Roy G. Williams Award for Meritorious Research in Basic Medical Sciences, 2013

American Heart Association Predoctoral Fellowship, 2009

Benjamin and Mary Siddons Measey Foundation Fellowship, 2005

Publication Highlights

Kadauke S. Should We Teach Data Science to Laboratorians-in-Training? . J Appl Lab Med. 2023 Jan; 8(1): 208-212. PMID: 36610425
Anderson DS, Hanna RS, Azar ARP, Collier V, Hankins P, Loudon B, Olson TS, Grupp SA, Phillips CA, Kadauke S. Automation of Hematopoietic Cell Transplant Outcomes Reporting Leads to Dramatic Reduction of Errors Reported to Real-World Data Registry Transplant . Cell Ther. 2023 Jan; S2666-6367(22)01875-9. PMID: 36610491
Chu Y, Milner J, Lamb M, Maryamchik E, Rigot O, Ayello J, Harrison L, Shaw R, Behbehani GK, Mardis ER, Miller K, Venkata LPR, Chang H, Lee D, Rosenthal E, Kadauke S, Bunin N, Talano JA, Johnson B, Wang Y, Cairo MS. Manufacture and Characterization of GMP-Compliant SARS-COV-2 Cytotoxic T Lymphocytes. J Infect Dis. 2022 Dec; jiac500. PMID: 36583990
Newman H, Li Y, Liu H, Myers RM, Tam V, DiNofia A, Wray L, Rheingold SR, Callahan C, White C, Baniewicz D, Winestone LE, Kadauke S, Diorio C, June CH, Getz K, Aplenc R, Teachey DT, Maude SL, Grupp SA, Bona K, Barz Leahy A. Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy Blood. Blood. 2022 Nov; blood.2022017866. PMID: 36351239
Leahy AB, Li Y, Talano JA, Elgarten CW, Seif AE, Wang Y, Johnson B, Monos DS, Kadauke S, Olson TS, Freedman J, Wray L, Grupp SA, Bunin N. Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia. Blood Adv. 2022 Feb; 6(4): 1175-1185. PMID: 34872106

Links of Interest